Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes
Huan Yang, Haichao Wang, Yaakov A. Levine, Manoj K. Gunasekaran, Yongjun Wang, Meghan Addorisio, Shu Zhu, Wei Li, Jianhua Li, Dominique P.V. de Kleijn, Peder S. Olofsson, H. Shaw Warren, Mingzhu He, Yousef Al-Abed, Jesse Roth, Daniel J. Antoine, Sangeeta S. Chavan, Ulf Andersson, Kevin J. Tracey
Huan Yang, Haichao Wang, Yaakov A. Levine, Manoj K. Gunasekaran, Yongjun Wang, Meghan Addorisio, Shu Zhu, Wei Li, Jianhua Li, Dominique P.V. de Kleijn, Peder S. Olofsson, H. Shaw Warren, Mingzhu He, Yousef Al-Abed, Jesse Roth, Daniel J. Antoine, Sangeeta S. Chavan, Ulf Andersson, Kevin J. Tracey
View: Text | PDF | Expression of Concern | Corrigendum
Research Article Hepatology Immunology

Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes

  • Text
  • PDF
Abstract

Secreted by activated cells or passively released by damaged cells, extracellular HMGB1 is a prototypical damage-associated molecular pattern (DAMP) inflammatory mediator. During the course of developing extracorporeal approaches to treating injury and infection, we inadvertently discovered that haptoglobin, the acute phase protein that binds extracellular hemoglobin and targets cellular uptake through CD163, also binds HMGB1. Haptoglobin-HMGB1 complexes elicit the production of antiinflammatory enzymes (heme oxygenase-1) and cytokines (e.g., IL-10) in WT but not in CD163-deficient macrophages. Genetic disruption of haptoglobin or CD163 expression significantly enhances mortality rates in standardized models of intra-abdominal sepsis in mice. Administration of haptoglobin to WT and to haptoglobin gene-deficient animals confers significant protection. These findings reveal a mechanism for haptoglobin modulation of the inflammatory action of HMGB1, with significant implications for developing experimental strategies targeting HMGB1-dependent inflammatory diseases.

Authors

Huan Yang, Haichao Wang, Yaakov A. Levine, Manoj K. Gunasekaran, Yongjun Wang, Meghan Addorisio, Shu Zhu, Wei Li, Jianhua Li, Dominique P.V. de Kleijn, Peder S. Olofsson, H. Shaw Warren, Mingzhu He, Yousef Al-Abed, Jesse Roth, Daniel J. Antoine, Sangeeta S. Chavan, Ulf Andersson, Kevin J. Tracey

×

Figure 6

Modulation of CD163 expression divergently affects haptoglobin-mediated HMGB1 endocytosis.

Options: View larger image (or click on image) Download as PowerPoint
Modulation of CD163 expression divergently affects haptoglobin-mediated ...
(A) Knockdown of CD163 impairs endocytosis of haptoglobin and HMGB1 complexes. The endocytosis of HMGB1 and haptoglobin complexes was measured by flow cytometric analysis. Primary human macrophages were transduced with CD163 shRNA lentiviral or vector alone (control) and incubated with FITC-labeled HMGB1 (1 μg/ml) plus haptoglobin (3 μg/ml) for 30 minutes. Endocytosis of FITC-HMGB1 was evaluated by measuring the fluorescence intensity of FITC-labeled protein as a function of CD163-PE signals. Data are representative of 5 experiments. (B) Overexpression of CD163 enhances endocytosis of haptoglobin and HMGB1 complexes. HEK 293 cells were transduced with human CD163 plasmid and incubated with FITC-HMGB1 alone (1 μg/ml) or a mixture of FITC-HMGB1 (1 μg/ml) and haptoglobin (3 μg/ml) for 30 minutes at 37°C. Endocytosis of FITC-HMGB1 was evaluated as described above, and data are representative of 4 repeats. (C) Dynasore (DYN) inhibits endocytosis of HMGB1 and haptoglobin complexes. Human macrophages on cover slips were incubated with Alexa Fluor 555–labeled HMGB1 alone (1 μg/ml) or in complex with haptoglobin (3 μg/ml) for 2 hours at 37°C. Dynasore (8 μM) was preincubated with cells for 30 minutes before the addition of HMGB1 and/or haptoglobin. Upper: Endocytic uptake of HMGB1 was visualized via Carl Zeiss fluorescence microscope (red). Nuclei were counterstained with DAPI (blue). Lower: Corresponding phase contrast image of cells. Scale bars: 10 µm. Data are representative from 8 independent experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts